Thorp Clay is a director of PhaseBio Pharmaceuticals Inc.
Person profile
Roles
Address
Durham, North Carolina
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Clearside Biomedical, Inc.
21 Jun 24
4
Clearside Biomedical, Inc.
25 Sep 23
4
Clearside Biomedical, Inc.
23 Jun 23
4
PhaseBio Pharmaceuticals Inc
19 May 23
4
Clearside Biomedical, Inc.
21 Dec 22
4
Clearside Biomedical, Inc.
19 Dec 22
4/A
Clearside Biomedical, Inc.
19 Dec 22
4
Clearside Biomedical, Inc.
24 Jun 22
4
PhaseBio Pharmaceuticals Inc
20 May 22
4
Vigil Neuroscience, Inc.
17 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Jun 24 | CLSD Clearside Biomedical | Stock Option Common Stock | Grant | Acquire A | No | No | 1.15 | 45,000 | 51.75 k | 45,000 |
25 Sep 23 | CLSD Clearside Biomedical | Common Stock | Buy | Acquire P | No | No | 0.86 | 10,000 | 8.60 k | 40,522 |
22 Jun 23 | CLSD Clearside Biomedical | Stock Option Common Stock | Grant | Acquire A | No | No | 1.31 | 30,000 | 39.30 k | 30,000 |
19 May 23 | PHASQ PhaseBio Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,750 | 0.00 | 36,693 |
19 May 23 | PHASQ PhaseBio Pharmaceuticals | RSU Common Stock | Option exercise | Acquire M | No | No | 0 | 3,750 | 0.00 | 0 |